Page last updated: 2024-10-22

anastrozole and Androgenization

anastrozole has been researched along with Androgenization in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Most children with non-classic congenital adrenal hyperplasia (NC-CAH) due to 21-hydroxylase deficiency are asymptomatic and do not require cortisol replacement therapy unless they develop symptoms of hyperandrogenemia."5.91Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia. ( Jaber, M; Liu, SC; Mercado Munoz, Y; Sarafoglou, K; Suresh, M, 2023)
"Most children with non-classic congenital adrenal hyperplasia (NC-CAH) due to 21-hydroxylase deficiency are asymptomatic and do not require cortisol replacement therapy unless they develop symptoms of hyperandrogenemia."1.91Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia. ( Jaber, M; Liu, SC; Mercado Munoz, Y; Sarafoglou, K; Suresh, M, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, SC1
Suresh, M1
Jaber, M1
Mercado Munoz, Y1
Sarafoglou, K1

Other Studies

1 other study available for anastrozole and Androgenization

ArticleYear
Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Adrenal Hyperplasia, Congenital; Anastrozole; Androgens; Child; Estrogens; Female; Humans; Hydrocort

2023